LRMR
Larimar Therapeutics
$2.54
+$0.15 (+6.28%)Oct 28, 2026
Key metrics
The numbers that frame LRMR today
- Market cap
- $263.86M
- ROIC
- -823%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.92
- 52wk High
- $6.42
Growth
Revenue and earnings trend for LRMR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about LRMR
Is Larimar Therapeutics a good buy?
No. Larimar Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Larimar Therapeutics is selling at a very high price.
What is the market capitalization of LRMR?
Larimar Therapeutics's market capitalization is $263.86M.
What is the 52-week high for LRMR stock?
The 52-week high for Larimar Therapeutics is $6.42. The current close of $2.54 is 60.4% below that high.
What is the 52-week low for LRMR stock?
The 52-week low for Larimar Therapeutics is $1.92. The current close of $2.54 is 32.6% above that low.
Does LRMR stock pay dividends?
Larimar Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for LRMR?
Larimar Therapeutics's Debt / Equity ratio is 0.04.